Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tela Bio Inc
(NQ:
TELA
)
4.570
-0.180 (-3.79%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
165,029
Open
4.780
Bid (Size)
1.830 (2)
Ask (Size)
5.640 (1)
Prev. Close
4.750
Today's Range
4.480 - 4.780
52wk Range
4.235 - 11.26
Shares Outstanding
24,649,595
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
April 15, 2024
Targets the more than 665,000 inguinal hernia procedures performed annually in the United States (U.S.)
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
April 08, 2024
Howard N. Langstein, MD, FACS joins innovative MedTech company to leverage his vast experience to help other surgeons optimize clinical outcomes in plastic and reconstructive surgery
From
TELA Bio, Inc.
Via
GlobeNewswire
Performance
YTD
-30.97%
-30.97%
1 Month
-15.99%
-15.99%
3 Month
-36.53%
-36.53%
6 Month
-19.26%
-19.26%
1 Year
-51.69%
-51.69%
More News
Read More
Recap: TELA Bio Q4 Earnings
March 21, 2024
Via
Benzinga
Preview: TELA Bio's Earnings
March 20, 2024
Via
Benzinga
Recap: TELA Bio Q3 Earnings
November 09, 2023
Via
Benzinga
TELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q4 2023
March 21, 2024
Via
InvestorPlace
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
March 21, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
March 20, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 21, 2024
March 21, 2024
Via
Benzinga
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
February 29, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 23, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 19, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 15, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Take Part in Connecting the Dots
December 05, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference
November 16, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 10, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
November 09, 2023
Via
Benzinga
TELA Bio Reports Third Quarter 2023 Financial Results
November 09, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Third Quarter 2023 Financial Results
October 26, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
September 18, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 9, 2023
November 09, 2023
Via
Benzinga
TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
August 16, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports Second Quarter 2023 Financial Results
August 09, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference
July 26, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.